Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy

Journal of Nutritional Biochemistry

Volumn 23, Issue 5, 2012, Pages 494-500

  Guerrero Beltrán, Carlos Enrique ^a,b   Mukhopadhyay, Partha ^a   Horváth, Béla ^a,c   Rajesh, Mohanraj ^a   Tapia, Edilia ^d   García Torres, Itzhel ^e   Pedraza Chaverri, José ^b   Pacher, Pál ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^e INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Cell death; Cisplatin; Inflammation; Natural compound; Nephropathy; Sulforaphane

Indexed keywords

CASPASE 3; CASPASE 7; CELL ADHESION MOLECULE; CISPLATIN; DNA FRAGMENT; ICAM PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE 14; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; SULFORAPHANE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VCAM PROTEIN;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ATTENUATION; BROCCOLI; CELL DEATH; CELL INFILTRATION; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; INFLAMMATORY CELL; KIDNEY; KIDNEY DISEASE; MALE; NEPHRITIS; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; RODENT; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BRASSICA; CELL DEATH; CISPLATIN; INFLAMMATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY DISEASES; MALE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; THIOCYANATES;

BRASSICA OLERACEA VAR. GEMMIFERA; BRASSICA OLERACEA VAR. ITALICA; RODENTIA;

EID: 84857615415     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.02.004     Document Type: Article

References (53)

1. Pabla N., Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008, 73:994-1007.
2. Baek S.M., Kwon C.H., Kim J.H., Woo J.S., Jung J.S., Kim Y.K. Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 2003, 142:178-186.
3. Cummings B.S., Schnellmann R.G. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther 2002, 302:8-17.
4. Jiang D.J., Jia S.J., Dai Z., Li Y.J. Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells. J Mol Cell Cardiol 2006, 40:529-539.
5. Liu H., Baliga R. Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis. J Am Soc Nephrol 2005, 16:1985-1992.
6. Liu L., Yang C., Herzog C., Seth R., Kaushal G.P. Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity. Biochem Pharmacol 2010, 79:137-146.
7. Mukhopadhyay P., Rajesh M., Batkai S., Patel V., Kashiwaya Y., Liaudet L., et al. CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res 2010, 85:773-784.
8. Mukhopadhyay P., Rajesh M., Pan H., Patel V., Mukhopadhyay B., Batkai S., et al. Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy. Free Radic Biol Med 2010, 48:457-467.
9. Pan H., Mukhopadhyay P., Rajesh M., Patel V., Mukhopadhyay B., Gao B., et al. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. J Pharmacol Exp Ther 2009, 328:708-714.
10. Park H.M., Cho J.M., Lee H.R., Shim G.S., Kwak M.K. Renal protection by 3H-1,2-dithiole-3-thione against cisplatin through the Nrf2-antioxidant pathway. Biochem Pharmacol 2008, 76:597-607.
11. Park M.S., De Leon M., Devarajan P. Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 2002, 13:858-865.
12. Ramesh G., Reeves W.B. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 2003, 285:F610-F618.
13. Ramesh G., Reeves W.B. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol 2005, 289:F166-F174.
14. Ries F., Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 1986, 8:368-379.
15. Santos N.A., Catao C.S., Martins N.M., Curti C., Bianchi M.L., Santos A.C. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Arch Toxicol 2007, 81:495-504.
16. Sugiyama S., Hayakawa M., Kato T., Hanaki Y., Shimizu K., Ozawa T. Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: disturbances in glutathione peroxidase activity. Biochem Biophys Res Commun 1989, 159:1121-1127.
17. Tsuruya K., Ninomiya T., Tokumoto M., Hirakawa M., Masutani K., Taniguchi M., et al. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 2003, 63:72-82.
18. Das S., Fraga C.G., Das D.K. Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB. Free Radic Res 2006, 40:1066-1075.
19. Jiang M., Wei Q., Pabla N., Dong G., Wang C.Y., Yang T., et al. Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol 2007, 73:1499-1510.
20. Luo J., Tsuji T., Yasuda H., Sun Y., Fujigaki Y., Hishida A. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant 2008, 23:2198-2205.
21. Mukherjee S., Lekli I., Das M., Azzi A., Das D.K. Cardioprotection with alpha-tocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation. Biochim Biophys Acta 2008, 1782:498-503.
22. Shi R., Huang Q., Zhu X., Ong Y.B., Zhao B., Lu J., et al. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Mol Cancer Ther 2007, 6:1338-1347.
23. Sung M.J., Kim D.H., Jung Y.J., Kang K.P., Lee A.S., Lee S., et al. Genistein protects the kidney from cisplatin-induced injury. Kidney Int 2008, 74:1538-1547.
24. Zhuang S., Lu B., Daubert R.A., Chavin K.D., Wang L., Schnellmann R.G. Suramin promotes recovery from renal ischemia/reperfusion injury in mice. Kidney Int 2009, 75:304-311.
25. Francescato H.D., Costa R.S., da Silva C.G., Coimbra T.M. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage. Life Sci 2009, 84:590-597.
26. Kang K.P., Kim D.H., Jung Y.J., Lee A.S., Lee S., Lee S.Y., et al. Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation. Nephrol Dial Transplant 2009, 24:3012-3020.
27. Ramesh G., Reeves W.B. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002, 110:835-842.
28. Dinkova-Kostova A.T., Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 2008, 52(Suppl 1):S128-S138.
29. Fahey J.W., Talalay P. Antioxidant functions of sulforaphane: a potent inducer of phase II detoxication enzymes. Food Chem Toxicol 1999, 37:973-979.
30. Shin D.H., Park H.M., Jung K.A., Choi H.G., Kim J.A., Kim D.D., et al. The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis. Free Radic Biol Med 2010, 48:1051-1063.
31. Yoon H.Y., Kang N.I., Lee H.K., Jang K.Y., Park J.W., Park B.H. Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem Pharmacol 2008, 75:2214-2223.
32. Zhao H.D., Zhang F., Shen G., Li Y.B., Li Y.H., Jing H.R., et al. Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway. World J Gastroenterol 2010, 16:3002-3010.
33. Song M.Y., Kim E.K., Moon W.S., Park J.W., Kim H.J., So H.S., et al. Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway. Toxicol Appl Pharmacol 2009, 235:57-67.
34. Shan Y., Zhao R., Geng W., Lin N., Wang X., Du X., et al. Protective effect of sulforaphane on human vascular endothelial cells against lipopolysaccharide-induced inflammatory damage. Cardiovasc Toxicol 2010, 10:139-145.
35. Davis R., Singh K.P., Kurzrock R., Shankar S. Sulforaphane inhibits angiogenesis through activation of FOXO transcription factors. Oncol Rep 2009, 22:1473-1478.
36. Jeffery E.H., Keck A.S. Translating knowledge generated by epidemiological and in vitro studies into dietary cancer prevention. Mol Nutr Food Res 2008, 52(Suppl 1):S7-S17.
37. Cheung K.L., Kong A.N. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 2010, 12:87-97.
38. Chirino Y.I., Sanchez-Gonzalez D.J., Martinez-Martinez C.M., Cruz C., Pedraza-Chaverri J. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 2008, 245:18-23.
39. Batkai S., Osei-Hyiaman D., Pan H., El-Assal O., Rajesh M., Mukhopadhyay P., et al. Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. FASEB J 2007, 21:1788-1800.
40. Moon K.H., Hood B.L., Mukhopadhyay P., Rajesh M., Abdelmegeed M.A., Kwon Y.I., et al. Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 2008, 135:1344-1357.
41. Mukhopadhyay P., Rajesh M., Batkai S., Kashiwaya Y., Hasko G., Liaudet L., et al. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol 2009, 296:H1466-H1483.
42. Kumar S., Allen D.A., Kieswich J.E., Patel N.S., Harwood S., Mazzon E., et al. Dexamethasone ameliorates renal ischemia-reperfusion injury. J Am Soc Nephrol 2009, 20:2412-2425.
43. Rajesh M., Mukhopadhyay P., Batkai S., Patel V., Saito K., Matsumoto S., et al. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol 2010, 56:2115-2125.
44. Wang D., Westerheide S.D., Hanson J.L., Baldwin A.S. Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 2000, 275:32592-32597.
45. Akcay A., Nguyen Q., Edelstein C.L. Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009, 2009:137072.
46. Di Pasqua A.J., Hong C., Wu M.Y., McCracken E., Wang X., Mi L., et al. Sensitization of non-small cell lung cancer cells to cisplatin by naturally occurring isothiocyanates. Chem Res Toxicol 2010, 23:1307-1309.
47. Kallifatidis G., Labsch S., Rausch V., Mattern J., Gladkich J., Moldenhauer G., et al. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther 2011, 19:188-195.
48. Hu R., Hebbar V., Kim B.R., Chen C., Winnik B., Buckley B., et al. In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J Pharmacol Exp Ther 2004, 310:263-271.
49. Shapiro T.A., Fahey J.W., Dinkova-Kostova A.T., Holtzclaw W.D., Stephenson K.K., Wade K.L., et al. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr Cancer 2006, 55:53-62.
50. Hanlon N., Coldham N., Gielbert A., Kuhnert N., Sauer M.J., King L.J., et al. Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat. Br J Nutr 2008, 99:559-564.
51. Hanlon N., Coldham N., Gielbert A., Sauer M.J., Ioannides C. Repeated intake of broccoli does not lead to higher plasma levels of sulforaphane in human volunteers. Cancer Lett 2009, 284:15-20.
52. Vermeulen M., Klopping-Ketelaars I.W., van den Berg R., Vaes W.H. Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli. J Agric Food Chem 2008, 56:10505-10509.
53. Myzak M.C., Tong P., Dashwood W.M., Dashwood R.H., Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood) 2007, 232:227-234.